Global Markets for Media, Sera and Reagents in Biotechnology

Report Code: BIO014L

Publish Date: Oct 2021

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for media, sera and reagents in biotechnology is estimated to grow from $5.0 billion in 2021 to $7.4 billion by 2026 at a compound annual growth rate (CAGR) of 7.9% of during the forecast period of 2021-2026.

Report Includes

  • 61 data tables and 44 additional tables
  • An updated review of current and future global markets for media, sera and reagents in the cell culture industry and its sub-segments
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Discussion of major factors driving the growth of this market, industry structure, regulatory scenario, and penetration of technologies related to media, sera, and reagents in biotechnology
  • Estimation of the market size and market forecast for global media, sera, and reagents in biotechnology, and corresponding market share analysis by product type, end use, and region
  • Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Japan, China, India, Australia and New Zealand, the Middle East and Africa
  • Highlights of emerging technology trends, opportunities and gaps estimating current and future demand for cell culture products; and impact analysis of COVID-19 on the progress of this market
  • A relevant patent analysis with significant allotments of patent issued for cell culture media, sera and reagents in biotechnology across each major category
  • Insight into the recent industry strategies, M&A deals of the major players operating within the global market; their key competitive landscape and company share analysis
  • Profile descriptions of the leading industry players, including Bio-Techne, Corning Inc., Fujifilm Holdings Corp., GE Healthcare, Merck KGaA and Thermo Fisher Scientific Inc.

Report Scope

The current report offers a detailed picture of media, sera and reagents in biotechnology.

This report highlights the current and future market potential for media, sera and reagents in biotechnology and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. This report also covers market projections through 2026 and key market players.

The report details market shares of media, sera and reagents in cell culture. Market analysis in the media segment is divided into specialty media and classical media based on composition. Based on formulation, the media are divided into powdered media and ready-to-use liquid media. Based on serum component, media are segmented into serum-free media and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera which includes sera from animal sources such as goats, porcine, rabbits, etc. The reagents market is segmented into reagents: biological response modifiers, cell dissociation reagents and others (amino acids, antibiotics, etc.). By geography, the market has been segmented into North America, Europe, the Asia-Pacific region, Middle East and Africa and South America. North America includes the U.S., Canada and Mexico, Europe includes Germany, the U.K., France, Italy, Spain and the Rest of Europe. The Asia-Pacific region includes China, India, Japan, Australia, New Zealand and the Rest of Asia-Pacific.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Media, Sera and Reagents in Biotechnology195Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background11Free
Chapter- 4: Impact of COVID-19 Pandemic2Free
Chapter- 5: Market Dynamics12Free
Chapter- 6: Market Breakdown by Product Type27Free
Chapter- 7: Market Breakdown by End Use11Free
Chapter- 8: Market Breakdown by Region42Free
Chapter- 9: Regulatory Scenarios7Free
Chapter- 10: Competitive Landscape6Free
Chapter- 11: Patent Analysis8Free
Chapter- 12: Company Profiles58Free
Published - Aug-2018| Analyst - BCC Publishing| Code - BIO014K

Report Highlights

The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.

Report Includes

  • 36 data tables and 32 additional tables
  • Detailed overview and industry analysis of the global markets for media, sera and reagents used in cell culture within the biotechnology industry
  • Country specific data and analysis for United States, Canada, Mexico, Germany, U.K., France, China, India, Japan, Middle East and Africa
  • Quantification of market potential by various segments of the media, sera and reagents as well as composition formula, geographical regions and end users
  • Assessment of the market dynamics and elaboration on the influence of competitive environment, regulatory scenario, technological advancement, and the economic factors that are and will shape the marketplace
  • Information on different types of cell cultures and products from cell culture technology as well as the advantages and disadvantages for the use of various types of media
  • Discussion covering the applications of cell culture technology with an emphasis on usage in the research, production, and contract segments
  • Company profiles of major players in the industry, including Athena Environmental Science, Inc., Becton, Dickinson and Company, CellGenix, GE Healthcare, Lonza, and Thermo Fisher Scientific, Inc.
Published - Jun-2017| Analyst - Shalini Shahani Dewan| Code - BIO014J

Report Highlights

The global market for media, sera and reagents used in cell culture will grow from nearly $3.6 billion in 2016 to $4.6 billion by 2021 at a compound annual growth rate (CAGR) of 5.5% between 2016 and 2021.

Report Includes

  • An overview of the global markets and technologies for media, sera and reagents used in biotechnology.
  • Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Information on different types of cell cultures and products from cell culture technology as well as the advantages and disadvantages for the use of various types of media.
  • Detailed analysis of the cell culture industry's structure.
  • Discussion covering the applications of cell culture technology with an emphasis on usage in the research, production, and contract segments.
  • Profiles of major players in the media, sera, and reagents industry.
Published - Mar-2015| Analyst - Shalini Shahani Dewan| Code - BIO014H

Report Highlights

The global market for cell culture products will grow from nearly $3.2 billion in 2014 to nearly $4.1 billion by 2019 at a compound annual growth rate (CAGR) of 5.1% between 2014 and 2019.

Report Includes

  • An overview of the global markets and technologies for media, sera and reagents used in biotechnology.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Information on different types of cell cultures and products from cell culture technology as well as the advantages and disadvantages for the use of various types of media are also covered.
  • Detailed analysis of the cell culture industry's structure.
  • Discussion covering the applications of cell culture technology with an emphasis on usage in the research, production and contract segments.
  • Comprehensive profiles of major players in the media, sera, and reagents industry.
Published - Apr-2012| Analyst - Shalini Shahani Dewan| Code - BIO014G

Report Highlights

The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%.

Published - Jul-2010| Analyst - Shalini Shahani Dewan| Code - BIO014F

Report Highlights

  • Total worldwide sales revenues for media, sera, and reagent used in the biotechnology were $2,546.2 million in 2010, and are expected to increase to more than $3800 Million in 2015, at a compound annual growth rate (CAGR) of 8.7%.
  • The largest biotechnology segments in 2010 were Reagents. All Reagents in Biotechnology will increase from $1,066.6 million in 2010 to nearly $1,850.4 million in 2015, at a compound annual growth rate (CAGR) of 11.6%.
  • Sales of Media will experience high growth. This market segment was worth $821.8 million in 2010 and will increase at a 8.6% compound annual growth rate (CAGR) to reach a value of $1,242.4 million in 2015.
  • Sales of Sera will experience moderate growth. This market segment was worth $31657.8 million in 2010 and will increase at a 3.3% compound annual growth rate (CAGR) to reach a value of $772.5 million in 2015.
Published - Mar-2007| Analyst - Shalini Shahani Dewan| Code - BIO014E

Report Highlights

  • The total U.S. sales of media, sera, and reagents for biotechnology was $979 million in 2005 and almost $1.1 billion in 2006. At a compound annual growth rate (CAGR) of 8.9%, this market will grow to reach more than $1.6 billion in 2011.
  • Sera will grow much more slowly in the market. This particular sector was worth $338.5 million in 2006 and will reach $401 million by 2011, a CAGR of just 3.5%
  • Reagents have the greatest potential for growth, worth $382 million in 2006 and growing at a CAGR of 12.8% to reach almost $700 million by 2011.
Published - Oct-2003| Analyst - Shalini Shahani Dewan| Code - BIO014D

Report Highlights

  • The market for media, sera and reagents in U.S. is estimated at $915.6 million in 2003. The market is expected to rise at an AAGR (average annual growth rate) of 13.1% and reach $1.7 billion by 2008.
  • U.S. sales for media are expected to reach $282.3 million in 2003 and $452.5 million in 2008, an AAGR of 9.9%.
  • The sera market, although slow, is rising at an AAGR of 3.5% and will reach $352.1 million in 2008 from $296.0 million in 2003.
  • The reagent market in 2003 is estimated at $337.3 million and is expected to rise at an AAGR of 21.5% and reach $892.6 million by 2008.
  • The reagent segment is the fastest growing, due to increases in expenditures for cell cultures. Ten to 12 new biological response modifiers are coming to market every year.

Published - Sep-2000| Analyst - Sanker Usha| Code - BIO014C

Report Highlights

  • The U.S. cell culture media market has been growing at a surprisingly fast pace since the last edition of this report, and some of the media suppliers are enjoying a growth rate higher than the overall rate. The U.S. market for cell culture media was estimated to be about $169.5 million in 1999. This is projected to grow to $190.2 million in 2000, and to reach $343.7 million in the year 2005. The estimated average annual growth rate is projected to be about 12.5%.
  • The sera portion of the U.S. market was an estimated $173.9 million in 1999. It should grow to $183.2 million by 2000, and $238.4 million by 2005. The average growth rate is expected to be 5.4% per year throughout this period.
  • The U.S. market for reagents used in cell culture was an estimated $151.7 million in 1999. This should grow to $170.4 million by 2000, and to $315.1 million by 2005. The average growth rate through this period is projected to be 13.0% per year.

Related Reports

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

Published - Aug 2023 | Publisher - BCC Publishing | Code - BIO115D

The global market for microRNA (miRNA) research tools is estimated to increase from $664.2 million in 2023 to $883.0 million by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.

Forensic Technologies: New and Growing Markets

Published - May 2023 | Publisher - BCC Publishing | Code - SAS003G

The global market for forensics technology is estimated to increase from $20.9 billion in 2022 to reach $42.1 billion by 2027, at a compound annual growth rate (CAGR) of 15.0% from 2022 through 2027.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Media, Sera and Reagents in Biotechnology
Customize Report